These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 12461659

  • 21. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D, Miquel R, Porrini E, Fernández A, González-Posada JM, Hortal L, Checa MD, Rodríguez A, García JJ, Rufino M, Torres A.
    Transplantation; 2007 Sep 27; 84(6):706-14. PubMed ID: 17893603
    [Abstract] [Full Text] [Related]

  • 22. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
    Morales JM, Campistol JM, Kreis H, Mourad G, Eris J, Schena FP, Grinyo JM, Nanni G, Andres A, Castaing N, Brault Y, Burke JT.
    Transplant Proc; 2005 Mar 27; 37(2):693-6. PubMed ID: 15848504
    [Abstract] [Full Text] [Related]

  • 23. Renal transplantation at the University of Minnesota during the 1980s.
    Fryd DS, Migliori R, Simmons RL, Chavers B, Dunn D, Payne W, Canafax DM, Sutherland DE, So SS, Mauer SM.
    Clin Transpl; 1987 Mar 27; ():167-81. PubMed ID: 3154396
    [Abstract] [Full Text] [Related]

  • 24. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 25. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
    Gallagher M, Jardine M, Perkovic V, Cass A, McDonald S, Petrie J, Eris J.
    Transplantation; 2009 Jun 27; 87(12):1877-83. PubMed ID: 19543068
    [Abstract] [Full Text] [Related]

  • 26. Effect of the immunosuppressive treatment on long-term renal graft survival.
    González Molina M, Sola E, Cabello M, García C, Luna E, Rodriguez Algarra G.
    Nephrol Dial Transplant; 2004 Jun 27; 19 Suppl 3():iii52-6. PubMed ID: 15192137
    [Abstract] [Full Text] [Related]

  • 27. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

  • 28. Retrospective study of the effects of cyclosporine in comparison with azathioprine on renal transplant recipients infected with hepatitis C virus.
    Ichikawa Y, Kishikawa H, Nishimura K, Tokugawa S, Yoshioka I, Arichi N, Fujii N, Kyo M, Nishikawa M.
    Transplant Proc; 2006 Dec 15; 38(10):3451-3. PubMed ID: 17175300
    [Abstract] [Full Text] [Related]

  • 29. Long-term use of cyclosporine A does not adversely impact on clinical outcomes following renal transplantation.
    Lewis RM.
    Kidney Int Suppl; 1995 Dec 15; 52():S75-8. PubMed ID: 8587289
    [Abstract] [Full Text] [Related]

  • 30. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
    Yu X, Zhang B, Xing C, Sun B, Liu M, Zhang W, Gu M.
    Transplant Proc; 2008 Dec 15; 40(10):3455-9. PubMed ID: 19100412
    [Abstract] [Full Text] [Related]

  • 31. Multiple drug combinations with "low-dose" cyclosporin for renal transplantation. Multivariate analysis of risk factors determining short-term graft survival within one renal transplant center.
    Hiesse C, Prevost P, Busson M, Lantz O, Cantarovich M, Bellamy J, Benoit G, Charpentier B, Fries D.
    Transpl Int; 1988 Oct 15; 1(3):149-54. PubMed ID: 3075474
    [Abstract] [Full Text] [Related]

  • 32. Evolution of rejection rates and kidney graft survival: a historical analysis.
    Marcén R, Fernández-Rodriguez A, Rodríguez-Mendiola N, Ponte B, Galeano C, Villafruela JJ, Teruel JL, Burgos FJ, Ortuño J.
    Transplant Proc; 2009 Oct 15; 41(6):2357-9. PubMed ID: 19715918
    [Abstract] [Full Text] [Related]

  • 33. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine.
    Halloran PF, Aprile MA, Farewell V, Ludwin D, Smith EK, Tsai SY, Bear RA, Cole EH, Fenton SS, Cattran DC.
    Transplantation; 1988 Aug 15; 46(2):223-8. PubMed ID: 3043779
    [Abstract] [Full Text] [Related]

  • 34. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov 15; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 35. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year.
    Rowshani AT, Scholten EM, Bemelman F, Eikmans M, Idu M, Roos-van Groningen MC, Surachno JS, Mallat MJ, Paul LC, de Fijter JW, Bajema IM, ten Berge I, Florquin S.
    J Am Soc Nephrol; 2006 Jan 15; 17(1):305-12. PubMed ID: 16306168
    [Abstract] [Full Text] [Related]

  • 36. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.
    MacDonell RC, Van Buren DH, Richie RE, Johnson HK, Nylander WA, Helderman JH, Ynares CM, Trusler LA, Green WF, Crowe DA.
    Transplant Proc; 1994 Oct 15; 26(5):2518-21. PubMed ID: 7940774
    [No Abstract] [Full Text] [Related]

  • 37. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.
    Sinclair NR.
    CMAJ; 1992 Sep 01; 147(5):645-57. PubMed ID: 1521210
    [Abstract] [Full Text] [Related]

  • 38. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K.
    Liver Transpl; 2003 Jun 01; 9(6):587-95. PubMed ID: 12783400
    [Abstract] [Full Text] [Related]

  • 39. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.
    Lucan M, Iacob G, Lucan C, Lăpuşan C, Munteanu A, Sîrbu S.
    Transplant Proc; 2004 Mar 01; 36(2 Suppl):177S-180S. PubMed ID: 15041332
    [Abstract] [Full Text] [Related]

  • 40. A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.
    Baboolal K.
    Transplantation; 2003 Apr 27; 75(8):1404-8. PubMed ID: 12717239
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.